[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363345-105":59,"doc-detail-363345-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","a-novel-prognostic-model-for-ovarian-cancer-construction-validation-and-therapeutic-insights","A novel prognostic model for ovarian cancer - construction, validation, and therapeutic insights","","Ovarian cancer is a highly lethal gynecological malignancy, and reliable biomarkers are needed to improve prognostic accuracy and guide personalized therapies. This study builds a prognostic model using palmitoylation-related genes and integrates transcriptome and clinical data from TCGA, GTEx, and GEO. Univariate Cox and Lasso-Cox analyses select features, while Kaplan-Meier and ROC assessments validate risk stratification performance. Immune infiltration, immune checkpoint expression, and drug sensitivity analyses support therapeutic relevance. ",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-prognostic-model-for-ovarian-cancer-construction-validation-and-therapeutic-insights/363345/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-prognostic-model-for-ovarian-cancer-construction-validation-and-therapeutic-insights/363345.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of this study?","Question",{"text":113,"@type":114},"To construct and validate a prognostic model for ovarian cancer based on palmitoylation-related genes, and to interpret its therapeutic implications.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which datasets are used to build and validate the model?",{"text":118,"@type":114},"The model is constructed using ovarian cancer transcriptome and clinical data from TCGA and validated using patient samples from both TCGA and GEO datasets.",{"name":120,"@type":111,"acceptedAnswer":121},"How is the model evaluated for prognostic performance?",{"text":122,"@type":114},"Performance is assessed using Kaplan-Meier survival analysis to separate high- and low-risk groups and ROC curve analysis to measure predictive accuracy.",{"name":124,"@type":111,"acceptedAnswer":125},"What additional analyses support potential treatment strategies?",{"text":126,"@type":114},"Analyses of immune cell infiltration, immune checkpoint expression levels, and drug sensitivity collectively suggest clinically relevant therapeutic directions.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},363345,1790210816,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":150,"preview_page_count":19,"preview_urls":151},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","OPEN ACCESS  \nEDITED BY  \nWenlin Yang,  \nUniversity of Florida, United States  \nREVIEWED BY  \nDuoYao Cao,  \nCedars Sinai Medical Center, United States Meng Liu,  \nYale University, United States  \n*CORRESPONDENCE  \nBolun Wang,  \n [wbl910427@163.com](wbl910427@163.com)[ ](wbl910427@163.com)Yuexin Yu,  \n [yuyuexinszyx@163.com](yuyuexinszyx@163.com)  \n†These authors have contributed equally to this work  \nRECEIVED 01 April 2025  \nREVISED 17 March 2026  \nACCEPTED 23 March 2026  \nPUBLISHED 22 April 2026  \nCITATION  \nYu T, Gao M, Yu Y and Wang B (2026) A novel prognostic model for ovarian cancer: construction, validation, and therapeutic insights.  \nFront. Genet. 17:1603788 .  \ndoi: 10.3389/fgene.2026.1603788  \nCOPYRIGHT  \n© 2026 Yu, Gao, Yu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTYPE Original Research PUBLISHED 22 April 2026  \nDOI 10.3389/fgene.2026.1603788  \nA novel prognostic model for ovarian cancer: construction, validation, and therapeutic insights  \nTingting Yu†, Mingyang Gao†, Yuexin Yu* and Bolun Wang* Department of Reproductive Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning, China  \nBackground: Ovarian cancer (OV) is the most lethal gynaecological malignancy worldwide. Palmitoylation, a reversible post-translational lipid modification, has been implicated in tumourigenesis, growth, metastasis and apoptosis across multiple cancers. However, its impact on immune infiltration, therapeutic response and clinical outcomes in ovarian cancer remains insufficiently explored. Methods: We obtained transcriptome data and clinical information pertaining to ovarian cancer from the Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and Gene Expression Omnibus (GEO) databases. A prognostic model based on palmitoylation-related genes was constructed using univariate Cox and Lasso-Cox regression for feature selection. The predictive performance of the model was assessed via Kaplan-Meier (KM) survival analysis and receiver operating characteristic (ROC) curve evaluation. Results: We developed a five-gene prognostic prediction model utilizing palmitoylation-related genes derived from TCGA samples of epithelial ovarian cancer patients. The validity of this model was confirmed using patient samples from both TCGA and GEO datasets. KM analysis demonstrated that our prognostic model effectively distinguished between high-risk and low-risk groups, correlating with poorer or more favorable outcomes respectively. According to ROC curve analysis, our model exhibited superior predictive accuracy compared to traditional clinical factors alone. Additionally, analyses regarding immune cell infiltration, expression levels of immune checkpoints, as well as drug sensitivity further support potential treatment strategies for ovarian cancer.  \nConclusion: The prognostic model developed in this study has the potential to enhance our understanding of the role of palmitic acid-related genes in ovarian cancer, providing new insights into prognosis prediction and treatment strategies for patients with ovarian cancer.  \nKEYWORDS  \ndrug sensitivity, immunotherapy, ovarian cancer, palmitoylation, prognostic model  \n1 Introduction  \nOvarian cancer (OV) is one of the most aggressive and lethal gynecological malignancies, characterized by a poor prognosis that results in over 207,252 cancerrelated deaths globally each year (Webb and Jordan, 2024) . While surgical resection combined with adjuvant chemotherapy can improve long-term survival rates for patients with resectable disease, most individuals are diagnosed at a","cbCairMuhkUUPPIx","https://ap.wps.com/l/cbCairMuhkUUPPIx","pdf",5325131,13,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the main goal of this study?\",\"answer\":\"To construct and validate a prognostic model for ovarian cancer based on palmitoylation-related genes, and to interpret its therapeutic implications.\"},{\"question\":\"Which datasets are used to build and validate the model?\",\"answer\":\"The model is constructed using ovarian cancer transcriptome and clinical data from TCGA and validated using patient samples from both TCGA and GEO datasets.\"},{\"question\":\"How is the model evaluated for prognostic performance?\",\"answer\":\"Performance is assessed using Kaplan-Meier survival analysis to separate high- and low-risk groups and ROC curve analysis to measure predictive accuracy.\"},{\"question\":\"What additional analyses support potential treatment strategies?\",\"answer\":\"Analyses of immune cell infiltration, immune checkpoint expression levels, and drug sensitivity collectively suggest clinically relevant therapeutic directions.\"}]","A novel prognostic model for ovarian cancer - construction, validation, and therapeutic insights | PDF",1790150879,33,[152,156,160,164],{"page_no":8,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c61af97ba4422f4ae58f44d51fc8f3f2.webp",983,1390,{"page_no":14,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3513c7a212486e38f39262ecfbee22fa.webp",982,1388,{"page_no":81,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e4dac4c1c5f5780285a646ff30df8b3.webp",981,1387,{"page_no":19,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbb6e87dd597ed1aa387bb7b6a4622df.webp",980,1385]